Author:
Khan Imran,Zakaria Mohammad Khalid,Kumar Mukesh,Mani Prashant,Chattopadhyay Parthaprasad,Sarkar Debi P,Sinha Subrata
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference35 articles.
1. Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno AF, Zhang L, Pridgen E et al (2008) HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem 3:1839–1843
2. Anderson DR, Grillo-López A, Varns C, Chambers KS, Hanna N (1997) Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin’s B-cell lymphoma. Biochem Soc Trans 25:705–708
3. Dotan E, Aggarwal C, Smith MR (2010) Impact of rituximab (rituxan) on the treatment of B-cell non-Hodgkin’s lymphoma. Pharm Ther 35:148–157
4. Fay F, Scott CJ (2011) Antibody-targeted nanoparticles for cancer therapy. Immunotherapy 3:381–394
5. Paszko E, Senge MO (2012) Immunoliposomes. Curr Med Chem 19:5239–5277
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献